Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study Ann R Falsey , Tessa Hosman , Arangassery Rosemary Bastian , Sjouke Vandenberghe , Eric K H Chan , Macaya Douoguih , Esther Heijnen , Christy A Comeaux , Benoit Callendret , Mohammed Allaw , Toby Briskin , Daniel Brune , Richard Egelhof , John Ervin , Ann Falsey , Carolos Fierro , David Fried , Peta-Gay Jackson-Booth , Murray Kimmel , Lorrie McGill , Paul Nugent , Suchet Patel , Barbara Rizzardi , James Ruhlmann , Cynthia Strout , Leslie Tharenos , Timothy Vachris , Tyler Wadsworth The Lancet Infectious Diseases（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
